DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence
Ein Podcast von DrugPatentWatch
Kategorien:
100 Folgen
-
Indian Pharma—Some Challenges and Acceptances
Vom: 21.12.2020 -
Essential Medicines and Patents
Vom: 15.12.2020 -
Drug Patent Expirations for the Week of November 29, 2020
Vom: 3.12.2020 -
New patent expiration for Cubist Pharms drug ENTEREG
Vom: 29.11.2020 -
Thinking of signing your company up for DrugPatentWatch?
Vom: 10.11.2020 -
Finding and Evaluating Generic Drug Market Entry Opportunities
Vom: 6.10.2020 -
Freedom of Information Act Access to an Investigational New Drug Application
Vom: 6.10.2020 -
Finding and Evaluating Generic Market Entry Opportunities
Vom: 24.9.2020 -
Getting the most out of pharmaceutical patent-term extensions in Russia
Vom: 22.9.2020 -
Switching to DrugPatentWatch
Vom: 22.9.2020 -
Government as the First Investor in Biopharmaceutical Innovation
Vom: 15.9.2020 -
Bloomberg and Drug PatentWatch: A “Perfect Storm” Affecting Generic Drugs
Vom: 15.9.2020 -
Finding hidden treasures in old drugs: the challenges and importance of licensing generics
Vom: 2.9.2020 -
Drug Repurposing: An Overview
Vom: 19.8.2020 -
Investing in Drug Companies? Here are 6 Vital Non-Patent Factors to Consider
Vom: 19.8.2020 -
Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market
Vom: 12.8.2020 -
Finding and Evaluating Market Entry Opportunities for a Better ROI
Vom: 4.8.2020 -
Free Patent Litigation Docket Reports Data
Vom: 30.7.2020 -
Free Orange Book PDF Library from DrugPatentWatch
Vom: 24.7.2020 -
A comprehensive review of database resources in chemistry
Vom: 16.7.2020
DrugPatentWatch serves leading companies ranging from biopharmaceutical R&D to healthcare delivery, and has been cited by CNN, NEJM, Nature Journals, and many other leading publications. Use cases for the DrugPatentWatch platform include: - Branded pharmaceutical global business intelligence and forecasting - Generic drug and API manufacturer portfolio management - Wholesalers preventing overstock of off-patent drugs - Healthcare payer formulary management and budget management